CNBX Pharmaceuticals Inc. (CNBX)

Market Cap	1.20M
Revenue (ttm)	n/a
Net Income (ttm)	-2.76M
Shares Out	1.26M
EPS (ttm)	-1.23
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	386,655
Open	0.0285
Previous Close	0.0250
Day's Range	0.0230 - 0.0300
52-Week Range	0.0200 - 12.0000
Beta	1.56
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About CNBX

CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of cannabinoid-based treatments and therapies for cancer. Its lead product candidate is RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal polyps during colonoscopy; BRST-33 to treat breast cancer; MLN-33 for the treatment of Melanoma; and ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 5
• Stock Exchange: OTCMKTS
• Ticker Symbol: CNBX